This week in aesthetics, we highlight baricitinib for hair regrowth in alopecia areata patients, the April “Meet the Aesthetic Expert” column, and more.
This week in aesthetics, a study highlights baricitinib for hair regrowth in alopecia areata patients, Will Kirby, DO, FAOCD, interviews Amy Spizuoco, DO, FAOCD, FAAD, in the April “Meet the Aesthetic Expert” column, a study examines the role of vitamin D in keloid scar treatment, and Michael Kluska, DO, discusses Evolve by InMode in his monthly device review.
Eli Lilly and Incyte announce results from its phase 3 study evaluating baricitinib 2 mg and 4 mg for the treatment of alopecia areata, making it the first phase 3 study with top-line results in patients with the hair disorder.
A recent study in the Journal of Cosmetic Dermatology examines the safety and efficacy of using vitamin D intralesional injection for the treatment of keloid scars.
In this month’s "Meet the Aesthetic Expert" column, Will Kirby, DO, FAOCD, talks with dual board-certified dermatologist and dermatopathologist Amy Spizuoco, DO, FAOCD, FAAD, about her new role as president-elect of AOCD, the coveted millennial patient population, and how to leverage health and beauty for a more holistic approach to aesthetics.
In this monthly technology review, Michael Kluska, DO, discusses Evolve by InMode, including device overview, cost, ROI, patient perceptions, and candidate considerations.